Clinical Trial Update: Antistax® in Patients With Chronic Venous Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 trial of Antistax for chronic venous insufficiency has completed, per a Boehringer Ingelheim–sponsored clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Insufficiency

Drugs mentioned

• Antistax (red vine leaf extract)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Insufficiency | Phase 2 | Status: COMPLETED